Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13728| Title: | Is Aerosolized Pentamidine for Pneumocystis Pneumonia Prophylaxis in Renal Transplant Recipients Not as Safe as We Might Think? | Austin Authors: | Macesic, Nenad;Urbancic, Karen F ;Ierino, F;Grayson, M Lindsay | Affiliation: | Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia Division of Infectious Diseases, Columbia University Medical Center Department of Nephrology, Austin Health, Heidelberg, Victoria, Australia Department of Medicine, University of Melbourne |
Issue Date: | Apr-2016 | Date: | 2016-01-11 | Publication information: | Antimicrobal Agents and Chemotherapy 2016; 60(4): 2502-2504 | Abstract: | Outbreaks of Pneumocystis pneumonia have been described in renal transplant recipients. Aerosolized pentamidine is frequently used for prophylaxis in this setting. We report our experience of aerosolized pentamidine use in 56 renal transplant recipients and find high rates of adverse reactions in patients with chronic respiratory disease. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/13728 | DOI: | 10.1128/AAC.02290-15 | Journal: | Antimicrobal Agents and Chemotherapy | PubMed URL: | 26824946 | Type: | Journal Article | Subjects: | Pneumocystis Pneumonia Kidney Transplantation |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.